What is Ingevity's cash and cash equivalents, end of period?

Ingevity (NGVT) reported cash and cash equivalents, end of period of $155.3M in Q1 2026.

How has Ingevity's cash and cash equivalents, end of period changed year-over-year?

Ingevity's cash and cash equivalents, end of period increased by 70.8% year-over-year, from $90.9M to $155.3M.

What is the long-term trend for Ingevity's cash and cash equivalents, end of period?

Over 2 years (2023 to 2025), Ingevity's cash and cash equivalents, end of period has grown at a 0.3% compound annual growth rate (CAGR), from $111.9M to $112.6M.

Ingevity NGVT Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

AvientAVNT

——

Other financials

Income statement

See full

Revenue$258.0M+4.1%

Gross profit$116.4M+4.0%

Net income$59.8M+192%

EPS (diluted)$1.66+196%

Balance sheet

See full

Cash & equivalents$95.4M+5.0%

Total debt$1.4B-9.0%

Total equity$38.9M-83.4%

Total assets$1.7B-19.7%

Cash flow

See full

Operating cash flow-$2.0M-108%

CapEx$10.3M+3.0%

Free cash flow-$12.3M-180%

Valuation

See full

Market cap$2.53B+73.9%

Enterprise value$3.8B+32.4%

P/S2.1×+0.9×

Profitability

See full

Gross margin39.3%+1.5pp

Net margin-10.6%-4.1pp

FCF margin20.3%+12.6pp

Returns & leverage

See full

Return on equity-93.5%+1.2pp

Debt / equity35.1×+28.7×

Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ingevity's cash and cash equivalents, end of period?: Ingevity (NGVT) reported cash and cash equivalents, end of period of $155.3M in Q1 2026.
How has Ingevity's cash and cash equivalents, end of period changed year-over-year?: Ingevity's cash and cash equivalents, end of period increased by 70.8% year-over-year, from $90.9M to $155.3M.
What is the long-term trend for Ingevity's cash and cash equivalents, end of period?: Over 2 years (2023 to 2025), Ingevity's cash and cash equivalents, end of period has grown at a 0.3% compound annual growth rate (CAGR), from $111.9M to $112.6M.